Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBLGNASDAQ:ICUNASDAQ:PAVMNASDAQ:SSKN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBLGBone Biologics$5.25+3.3%$4.58$3.42▼$25.50$2.77M0.75236,093 shs21,815 shsICUSeaStar Medical$0.98+1.0%$1.24$0.95▼$13.85$10.88M-0.89264,631 shs106,485 shsPAVMPAVmed$0.61-0.3%$0.68$0.55▼$1.90$10.45M1.06131,953 shs70,708 shsSSKNStrata Skin Sciences$2.36+3.5%$2.52$2.10▼$3.80$9.51M0.712,815 shs5,121 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBLGBone Biologics+3.35%+6.92%+17.83%+6.45%-41.28%ICUSeaStar Medical+0.94%-20.97%-22.22%-52.43%-76.21%PAVMPAVmed-0.26%-11.59%-3.14%-20.47%-34.05%SSKNStrata Skin Sciences+3.51%+3.51%-4.84%-9.75%-24.84%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBBLGBone Biologics1.2957 of 5 stars0.05.00.00.02.00.01.3ICUSeaStar Medical0.3096 of 5 stars0.03.00.00.00.81.70.0PAVMPAVmed4.0503 of 5 stars3.53.00.04.30.60.01.9SSKNStrata Skin Sciences2.179 of 5 stars3.53.00.00.00.61.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBLGBone Biologics 0.00N/AN/AN/AICUSeaStar Medical 0.00N/AN/AN/APAVMPAVmed 3.00Buy$19.003,014.75% UpsideSSKNStrata Skin Sciences 3.00Buy$6.00154.24% UpsideCurrent Analyst Ratings BreakdownLatest BBLG, PAVM, ICU, and SSKN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025PAVMPAVmedAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.50 ➝ $19.004/21/2025PAVMPAVmedAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $19.50(Data available from 6/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBLGBone BiologicsN/AN/AN/AN/A$8.39 per shareN/AICUSeaStar Medical$140K78.40N/AN/A($0.34) per share-2.88PAVMPAVmed$2.99M3.49N/AN/A($0.92) per share-0.66SSKNStrata Skin Sciences$33.56M0.29N/AN/A$1.19 per share1.98Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBLGBone Biologics-$4.11MN/A0.00N/AN/AN/A-130.21%-119.39%8/8/2025 (Estimated)ICUSeaStar Medical-$24.83M-$3.47N/A∞N/AN/AN/A-313.28%8/11/2025 (Estimated)PAVMPAVmed$39.79M$0.710.86N/AN/A3,711.54%N/A-42.29%8/12/2025 (Estimated)SSKNStrata Skin Sciences-$10.09M-$2.27N/AN/AN/A-27.22%-138.22%-24.37%8/13/2025 (Estimated)Latest BBLG, PAVM, ICU, and SSKN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025ICUSeaStar Medical-$0.52-$0.44+$0.08-$0.44$0.15 million$0.29 million5/14/2025Q1 2025SSKNStrata Skin Sciences-$0.56-$0.58-$0.02-$0.58$7.28 million$6.81 million5/12/2025Q1 2025BBLGBone Biologics-$2.88-$1.92+$0.96-$0.32N/AN/A3/27/2025Q4 2024ICUSeaStar Medical-$0.89-$0.90-$0.01-$0.90$0.15 million$0.07 million3/27/2025Q4 2024SSKNStrata Skin Sciences-$0.40-$1.13-$0.73-$1.13$9.03 million$33.56 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBBLGBone BiologicsN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/APAVMPAVmedN/AN/AN/AN/AN/ASSKNStrata Skin SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBLGBone BiologicsN/A12.6012.60ICUSeaStar MedicalN/A0.960.96PAVMPAVmedN/A0.370.37SSKNStrata Skin Sciences5.711.050.87Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBLGBone Biologics34.30%ICUSeaStar Medical1.69%PAVMPAVmed19.93%SSKNStrata Skin Sciences32.43%Insider OwnershipCompanyInsider OwnershipBBLGBone Biologics6.10%ICUSeaStar Medical1.30%PAVMPAVmed7.30%SSKNStrata Skin Sciences39.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBLGBone Biologics2550,000512,000Not OptionableICUSeaStar Medical211.20 million10.22 millionNot OptionablePAVMPAVmed9017.09 million15.85 millionOptionableSSKNStrata Skin Sciences1204.17 million2.54 millionNot OptionableBBLG, PAVM, ICU, and SSKN HeadlinesRecent News About These CompaniesSTRATA Skin Sciences Gains CPT Code Expansion For Excimer Laser Use In Skin Inflammatory DiseasesMay 21, 2025 | nasdaq.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comSTRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comSTRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 14, 2025 | globenewswire.com3SSKN : A Peek at Strata Skin Sciences's Future EarningsMay 13, 2025 | benzinga.comStrata Skin Sciences Inc (SSKN) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 13, 2025 | finance.yahoo.comSTRATA Skin Sciences to Join D. Boral Capital’s Inaugural Global Conference in NYCMay 11, 2025 | msn.comSTRATA Skin Sciences to Announce Q1 2025 Financial Results and Host Investor CallMay 11, 2025 | msn.comSTRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate UpdateMay 9, 2025 | seekingalpha.comSTRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global ConferenceMay 8, 2025 | globenewswire.comSTRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate UpdateMay 7, 2025 | globenewswire.comStrata Skin Sciences price target lowered to $14 from $16 at LadenburgMarch 31, 2025 | markets.businessinsider.comEarnings call transcript: STRATA Skin Sciences Q4 2024 revenue rises 10%March 29, 2025 | uk.investing.comSTRATA Skin Sciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsMarch 29, 2025 | finance.yahoo.comSTRATA SKIN SCIENCES Earnings Results: $SSKN Reports Quarterly EarningsMarch 29, 2025 | nasdaq.comStrata Skin Sciences (SSKN) Gets a Buy from Maxim GroupMarch 29, 2025 | markets.businessinsider.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | insidermonkey.comSTRATA Skin Sciences Reports Strong Q4 Growth and Strategic ProgressMarch 29, 2025 | msn.comQ4 2024 STRATA Skin Sciences Inc Earnings CallMarch 28, 2025 | finance.yahoo.comStrata Skin Sciences reports Q4 EPS ($1.18), consensus (40c)March 28, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s Watching3 Industrials Stocks Standing Out for Growth and Analyst OptimismBy Nathan Reiff | June 4, 2025View 3 Industrials Stocks Standing Out for Growth and Analyst OptimismWhich U.S. Towns See Economic Change First? [2025 Survey]By MarketBeat Staff | June 9, 2025View Which U.S. Towns See Economic Change First? [2025 Survey]BBLG, PAVM, ICU, and SSKN Company DescriptionsBone Biologics NASDAQ:BBLG$5.25 +0.17 (+3.35%) Closing price 06/18/2025 03:58 PM EasternExtended Trading$5.25 0.00 (0.00%) As of 06/18/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.SeaStar Medical NASDAQ:ICU$0.98 +0.01 (+1.03%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$0.99 +0.01 (+1.33%) As of 06/18/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.PAVmed NASDAQ:PAVM$0.61 0.00 (-0.26%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$0.64 +0.03 (+4.92%) As of 06/18/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.Strata Skin Sciences NASDAQ:SSKN$2.36 +0.08 (+3.51%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$2.38 +0.02 (+1.06%) As of 06/18/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Chime’s Smart IPO: Half the Valuation, Double the Strength Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Tesla Bulls and Bears Collide: What Investors Should Know Qualcomm: A Technical Setup Is Emerging, and It's Bullish Why Amazon Could Be About To Breakout To $250 330% Returns YTD: Is CoreWeave's Momentum Softening? Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
